We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
726
DELISTED
Xilinx Inc
XLNX
$2.27M 0.01%
47,900
+11,400
+31% +$549K
FAST icon
727
Fastenal
FAST
$56.3B
$2.21M 0.01%
178,304
+64,000
+56% +$792K
LLTC
728
DELISTED
Linear Technology Corp
LLTC
$2.2M 0.01%
46,771
+15,471
+49% +$717K
CUBE icon
729
CubeSmart
CUBE
$8.94B
$2.2M 0.01%
120,000
+68,500
+133% +$1.25M
ESV
730
DELISTED
Ensco Rowan plc
ESV
$2.19M 0.01%
9,841
+2,226
+29% +$461K
THI
731
DELISTED
TIM HORTONS INC COM, CANADA
THI
$2.18M 0.01%
39,700
+12,600
+46% +$691K
DFT
732
DELISTED
DuPont Fabros Technology Inc.
DFT
$2.17M 0.01%
80,492
– –
PMC
733
DELISTED
PharMerica Corporation
PMC
$2.16M 0.01%
75,500
-17,300
-19% -$481K
VRSK icon
734
Verisk Analytics
VRSK
$23.7B
$2.15M 0.01%
35,900
+13,300
+59% +$795K
VALE.P
735
DELISTED
Vale S A
VALE.P
$2.15M 0.01%
180,804
– –
AME icon
736
Ametek
AME
$53.2B
$2.15M 0.01%
41,146
+16,266
+65% +$855K
DINO icon
737
HF Sinclair
DINO
$20.3B
$2.13M 0.01%
48,657
-99,875
-67% -$4.9M
UGP icon
738
Ultrapar
UGP
$8.06B
$2.13M 0.01%
180,138
– –
AHL
739
DELISTED
ASPEN Insurance Holding Limited
AHL
$2.12M 0.01%
46,700
-24,600
-35% -$1.1M
FTI icon
740
TechnipFMC
FTI
$28.5B
$2.11M 0.01%
46,470
+15,961
+52% +$676K
BWA icon
741
BorgWarner
BWA
$12.7B
$2.09M 0.01%
36,435
+14,965
+70% +$824K
ABM icon
742
ABM Industries
ABM
$2.95B
$2.08M 0.01%
77,000
– –
BBWI icon
743
Bath & Body Works
BBWI
$3.37B
$2.07M 0.01%
43,745
+15,181
+53% +$695K
WRI
744
DELISTED
Weingarten Realty Investors
WRI
$2.07M 0.01%
63,000
+3,900
+7% +$123K
CHKP icon
745
Check Point Software Technologies
CHKP
$14.1B
$2.06M 0.01%
30,794
-824
-3% -$54.2K
ISRG icon
746
Intuitive Surgical
ISRG
$135B
$2.06M 0.01%
45,000
+14,400
+47% +$635K
UPBD icon
747
Upbound Group
UPBD
$1.04B
$2.06M 0.01%
71,800
+8,600
+14% +$243K
JNS
748
DELISTED
Janus Capital Group Inc
JNS
$2.04M 0.01%
163,800
+5,100
+3% +$60K
OUTR
749
DELISTED
OUTERWALL INC
OUTR
$2.04M 0.01%
34,300
-2,000
-6% -$135K
NMFC icon
750
New Mountain Finance
NMFC
$660M
$2.03M 0.01%
136,469
+77,366
+131% +$1.11M
28 29
30
31 32

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.